Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Apo-Valsartan/HCTZ 160/12.5mg*


Contraindicated
Foetotoxicity

Contraindicated
Apo-Valsartan/HCTZ 160/12.5mg* :
Type Medicine Non Marketed
Originator Co-Diovan 160/12.5mg
Agent Promopharm
Distributor Promopharm
Laboratory Apotex
Responsible Party Apotex Inc
Origin Canada
Manufacturer Apotex Inc
Manufacturing Type G
Origin Canada
ATC C09DA03

Your comment will appear shortly after approval

Apo-Valsartan/HCTZ 160/12.5mg* :

Revision Date : 01/05/2015


Effect Frequency
Arthralgia (Pain joint) (Joint ache) Very rare
Blood bilirubin increased Not known
Blood urea increased Not known
Blood uric acid increased Not known
Cough Uncommon
Dehydration Uncommon
Diarrhoea (Diarrhea) Very rare
Dizziness Very rare
Fatigue Uncommon
Hypokalaemia Not known
Hyponatraemia (Hyponatremia) Not known
Hypotension Uncommon
Kidney function abnormal Not known
Myalgia Uncommon
Neutropenia Not known
Non-cardiogenic pulmonary oedema Not known
Paraesthesia (paresthesia) Uncommon
Serum creatinine increased Not known
Syncope Not known
Tinnitus Uncommon
Vision blurred Uncommon

Different Units By MoH Code

Revision Date : 04/09/2015

Revision Date : 04/09/2015

Apo-Valsartan/HCTZ 160/12.5mg*  MoH 8137 :
Form Tablet
Package Size Box of 30
Strength 160/12.5mg
Storage Condition <30°C Protect from excessive heat and moisture
NSSF ✘
Quarantine ✘
Reg. Number 187161/13
Submission date 01/01/2013
Registration Year 2015
Archived Date 2018


Price Comparison

● Country: Spain
● Package Size: 28
● Public Price: 11.99 EUR ( 1,161,543.24 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,4282 EUR ( 0.00 LBP )
● Medica Comments: Non Marketed
● Reference: Agencia Española de Medicamentos y Productos Sanitarios
● Pricing Date: 06/05/2021
● Type: Medicine Non Marketed

● Country: The Netherlands
● Package Size: 30
● Reference: Zorginstituut Nederland
● Pricing Date: 15/06/2019
● Type: Medicine Non Marketed

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info